Menthone

Menthone is a naturally occurring cyclic monoterpene ketone found predominantly in peppermint (Mentha piperita) and pennyroyal oils, comprising up to 20–30% of peppermint essential oil composition. It exerts its primary biological effects through interactions with TRPM8 cold receptors and inhibition of acetylcholinesterase, though no human clinical trials have confirmed therapeutic benefits.

Origin & History

Menthone is a naturally occurring monoterpenoid ketone found in peppermint and other mint plants. It is typically obtained through steam distillation of mint oils followed by fractional distillation or synthesis. Commercially available menthone has purities of ≥90% or ≥95%.

Historical & Cultural Context

There are no documented historical or traditional medicinal uses of menthone in specific cultural systems according to the research provided.

Health Benefits

• No specific health benefits have been demonstrated in human studies, as no clinical trials or meta-analyses have been identified.

How It Works

Menthone acts as a partial agonist at TRPM8 (transient receptor potential melastatin 8) cold-sensing ion channels, though with lower potency than its structural analog menthol, producing mild cooling and analgesic-adjacent sensory effects. In vitro studies suggest menthone inhibits acetylcholinesterase activity, potentially modulating cholinergic neurotransmission. Additionally, menthone has demonstrated concentration-dependent inhibition of cytochrome P450 enzymes, particularly CYP2A6 and CYP2B6, in cell-based assays, which may underlie observed antifungal and antimicrobial properties against organisms such as Candida albicans and Staphylococcus aureus.

Scientific Research

There are no human clinical trials, RCTs, or meta-analyses available for menthone. As such, no PubMed PMIDs or specific study details are provided in the research dossier.

Clinical Summary

No published randomized controlled trials or meta-analyses have specifically evaluated menthone as an isolated compound in human subjects, making definitive clinical conclusions impossible. The existing evidence base consists entirely of in vitro cell culture studies and animal model experiments, which cannot be directly extrapolated to human therapeutic outcomes. Rodent studies have examined menthone's neurotoxic potential at high doses, with pennyroyal oil (a menthone-rich source) associated with documented hepatotoxicity cases in humans following ingestion of large quantities. The overall evidence for any health benefit of isolated menthone remains preclinical and insufficient to support supplemental use.

Nutritional Profile

Menthone (C₁₀H₁₈O, molecular weight 154.25 g/mol) is a monoterpene ketone, not a nutritional compound per se, and thus lacks a conventional nutritional profile of macronutrients, vitamins, or minerals. Key details: • It is a major constituent of several essential oils, primarily cornmint (Mentha arvensis) oil (20–30%), pennyroyal (Mentha pulegium) oil (10–30%), and to a lesser extent peppermint (Mentha × piperita) oil (14–32% in some chemotypes, though menthol typically dominates). • Exists as two enantiomers: (−)-menthone (more common in peppermint) and (+)-menthone (isomenthone is a related diastereomer). • Caloric contribution is negligible at levels encountered in food flavoring (typically 0.1–5 mg per serving in flavored foods/beverages). • Contains no protein, carbohydrates, fat, fiber, vitamins, or minerals. • As a lipophilic monoterpenoid (log P ~2.8), it is readily absorbed through oral and dermal routes; oral bioavailability is presumed to be high based on rapid absorption kinetics observed in animal models. • Hepatic metabolism proceeds via reduction to menthol and hydroxylation, followed by glucuronidation and urinary excretion. • Bioactive concentration in essential oil applications: when present in peppermint oil supplements (typical dose 0.2–0.4 mL per enteric-coated capsule), menthone content ranges from approximately 28–80 mg per capsule depending on chemotype. • No significant antioxidant capacity (ORAC values not established); unlike menthol, menthone does not activate TRPM8 cold receptors appreciably but may modestly interact with TRPA1 channels. • ADI (Acceptable Daily Intake) set by FEMA GRAS status for flavoring use; JECFA has evaluated it as part of the mint-derived flavoring group with no safety concerns at typical dietary exposure levels (estimated dietary exposure ~0.02–0.1 mg/kg body weight/day in Western diets). • No micronutrient cofactor roles identified.

Preparation & Dosage

No clinically studied dosage ranges or forms are available due to the lack of human trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Menthol, peppermint oil, eucalyptus oil, camphor, spearmint oil

Safety & Interactions

Pennyroyal oil, which contains high concentrations of menthone alongside pulegone, has caused severe hepatotoxicity, nephrotoxicity, and fatalities in humans who ingested it as an abortifacient, and is considered unsafe for oral consumption. Menthone alone at high doses has demonstrated neurotoxicity and convulsant potential in animal studies, raising concerns about concentrated supplemental forms. Due to menthone's inhibition of CYP2A6 and CYP2B6 enzymes in vitro, potential interactions with drugs metabolized by these pathways — including nicotine, efavirenz, and cyclophosphamide — cannot be excluded. Menthone-containing preparations are contraindicated during pregnancy due to the abortifacient history of pennyroyal and absence of safety data in pregnant populations.